FONT-SIZE Plus   Neg

Christopher Reidy Named BD's CFO - Quick Facts

Medical technology firm Becton, Dickinson and Co. or BD (BDX) has named Christopher Reidy as Chief Financial Officer and Executive Vice President of Administration, effective July 15, 2013. He would report to Vincent Forlenza, Chairman, Chief Executive and President.

Reidy would be accountable for executive management and oversight of BD's global financial operations and shared services, as well as oversight of Information Technology after a transition period. He joins BD from ADP Corp., where he served as Corporate Vice President and CFO for 6 years. Prior to ADP, Reidy's over 30 years of experience includes serving as CFO at NBA Properties, Inc.; Vice President, Controller & Chief Accounting Officer and division CFO roles at AT&T Corporation; and Audit Partner at Deloitte & Touche.

Suketu Upadhyay, who was serving as Acting Chief Financial Officer since November 2012, would have expanded responsibilities across BD's finance organization and would serve as the company's principal accounting officer in his new role as Senior Vice President, Finance, also with effect from July 15, 2013.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Apple confirmed that it has bought face animation software firm Faceshift, although it was tight lipped about how it intends to use the new addition. The move is speculated as a bid to expand into virtual reality. Environment ministry of South Korea Thursday ordered Volkswagen Korea to recall 125,522 diesel vehicles on determining actual emissions of nitrogen oxides. The ministry has asked the German automobile maker to pay a fine of 14.1 billion Won or $12.31 million. The company has to submit a recall plan by January 6, 2016. The U.S. Food and Drug Administration has alerted health care professionals and patients of a voluntary recall of compounded multivitamin capsules containing high amounts of Vitamin D3 (Cholecalciferol), distributed nationwide by Glades Drugs in Pahokee, Florida. FDA has received reports of several...
comments powered by Disqus
Follow RTT